Market Overview

Analysts Getting More Bullish On ViroPharma Following Friday's 28+% Surge On Takeover Chatter

Related VPHM
US Stock Futures Signal Flat Start On Wall Street
Shire Extends Tender Offer for ViroPharma to Thursday, January 9, 2014
Mario Gabelli Comments on ViroPharma (GuruFocus)

ViroPharma (NASDAQ: VPHM) shares are up about three-quarters of a percent Monday morning on the heels of a 28-plus percent move higher on Friday. Traders in the name were responding to chatter the company had received offers from both Sanofi (NYSE: SNY) and Shire (NASDAQ: SHPG).

Monday morning numerous analysts are commenting and raising price targets on ViroPharma.

  • Stifel Nicolaus raised target from $41 to $47, Buy rating maintained.
  • Piper Jaffray target from $37 to $46, Overweight maintained.
  • Oppenheimer target from $35 to $44, Outperform maintained.
  • Mizuho sees value of $45 assuming cost savings if M&A does happen, believes could include a contingent value of $2-3/share related to cinryze.

ViroPharma shares last traded at $39.41.

Latest Ratings for VPHM

Nov 2013Stifel NicolausDowngradesBuyHold
Nov 2013JP MorganDowngradesOverweightNeutral
Nov 2013Piper JaffrayDowngradesOverweightNeutral

View More Analyst Ratings for VPHM
View the Latest Analyst Ratings

Posted-In: Analyst Color News Rumors Price Target M&A Analyst Ratings Movers


Related Articles (SNY + SHPG)

Around the Web, We're Loving...

Get Benzinga's Newsletters